BiomX Inc Sustainability Reports
BiomX Inc. is a clinical-stage biotechnology company that develops natural and engineered phage cocktails designed to target and destroy harmful bacteria. Its treatments focus on chronic diseases with substantial unmet medical needs, such as cystic fibrosis and inflammatory bowel disease.
Sector: Manufacturing
Country: United States
Exchange: NYSE American
ISIN: US09090D1037
4 reports from 2021 to 2024